Literature DB >> 7181498

Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

K V Rolston, J L LeFrock, R F Schell.   

Abstract

The activity of nine antimicrobial agents against 44 strains of group C and group G streptococci was studied using a microtiter broth dilution technique. Several antimicrobial agents, including third-generation cephalosporins, the newer semisynthetic penicillins, and erythromycin, exhibited good activity against the organisms. Occasional tolerance to various agents was observed. No cross-tolerance was observed in this study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181498      PMCID: PMC185690          DOI: 10.1128/AAC.22.5.930

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Group G streptococcal endocarditis.

Authors:  E Bouza; R D Meyer; D F Busch
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

2.  Primary peritonitis due to group G Streptococcus: A case report.

Authors:  A J Khan; H E Evans; M R Macabuhay; Y Lee; R Werner
Journal:  Pediatrics       Date:  1975-12       Impact factor: 7.124

3.  Identification of streptococcal groups A,B,C, and G by slide co-agglutination of antibody-sensitized protein A-containing staphylococci.

Authors:  G Hahn; I Nyberg
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

4.  Penicillin tolerance in experimental streptococcal endocarditis.

Authors:  L Pulliam; S Inokuchi; W K Hadley; J Mills
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

5.  Antimicrobial tolerance in group G streptococci.

Authors:  J T Noble; M B Tyburski; M Berman; J Greenspan; M J Tenenbaum
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

6.  Neonatal meningitis due to group C beta hemolytic streptococcus.

Authors:  P Stewardson-Krieger; S P Gotoff
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

7.  Bacterial endocarditis due to a penicillin-tolerant group C streptococcus.

Authors:  D Portnoy; I Wink; G K Richards; M Z Blanc
Journal:  Can Med Assoc J       Date:  1980-01-12       Impact factor: 8.262

8.  Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.

Authors:  A L Barry; R N Jones; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

9.  Infections due to group C streptococci in man.

Authors:  D N Mohr; D J Feist; J A Washington; P E Hermans
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

10.  Group G streptococcus.

Authors:  C U Tuazon
Journal:  Am J Med Sci       Date:  1980 Mar-Apr       Impact factor: 2.378

View more
  18 in total

1.  Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features.

Authors:  Anna Bläckberg; Bo Nilson; Volkan Özenci; Lars Olaison; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-08       Impact factor: 3.267

2.  Toxic shock syndrome due to group C streptococci. A case report.

Authors:  S Natoli; C Fimiani; N Faglieri; L Laurenzi; A Calamaro; A M Frasca; E Arcuri
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates.

Authors:  T Zaoutis; L S Moore; K Furness; J D Klein
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Multiply resistant Streptococcus mitis isolated from conjunctival exudate of newborns.

Authors:  S Kontiainen; A Sivonen
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

Review 5.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Penicillin susceptibility testing of Lancefield group C and G streptococci by the modified stokes method.

Authors:  B Kirkpatrick; H A Holt; S Y McCulloch; A P MacGowan; D S Reeves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

7.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

8.  Clinical features and antimicrobial therapy of infections caused by group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

9.  Biotyping and exoenzyme profiling as an aid in the differentiation of human from bovine group G streptococci.

Authors:  R B Clark; J F Berrafati; J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

Review 10.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.